GLP1R and intestinal neuroendocrine neoplasm: γ-[Glu](n = 1,2)-Phe/-Met/-Val upregulated the activation of CaSR and engendered Ca2+ mobilization, leading to GLP-1 release from intestinal neuroendocrine tumor STC-1 cells [64].